Advertisement
GERN vs PULM
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GERN is a StrongBuy and PULM is a Hold.
GERN in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 21, 2026
GERN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 40 of 47 cases where GERN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 85%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GERN's RSI Oscillator exited the oversold zone, 22 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 76%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 59 of 70 cases where GERN's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for GERN just turned positive on October 08, 2026. Looking at past instances where GERN's MACD turned positive, the stock continued to rise in 42 of 53 cases over the following month. The odds of a continued upward trend are 79%.
Following a +5.98% 3-day Advance, the price is estimated to grow further. Considering data from situations where GERN advanced for three days, in 168 of 218 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 21, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on GERN as a result. In 89 of 102 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.
The 50-day moving average for GERN moved below the 200-day moving average on September 24, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GERN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
The Aroon Indicator for GERN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 19 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 75 (best 1 - 100 worst), indicating slightly worse than average price growth. GERN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.321) is normal, around the industry mean (2.973). P/E Ratio (-10.273) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (16.670) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (4.250) is also within normal values, averaging (438.009).
The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GERN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
PULM sees its Stochastic Oscillator ascends from oversold territory
On October 21, 2026, the Stochastic Oscillator for PULM moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 68 instances where the indicator left the oversold zone. In 53 of the 68 cases the stock moved higher in the following days. This puts the odds of a move higher at over 78%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for PULM just turned positive on October 21, 2026. Looking at past instances where PULM's MACD turned positive, the stock continued to rise in 32 of 48 cases over the following month. The odds of a continued upward trend are 67%.
Following a +10.56% 3-day Advance, the price is estimated to grow further. Considering data from situations where PULM advanced for three days, in 166 of 231 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.
Bearish Trend Analysis
The 10-day RSI Indicator for PULM moved out of overbought territory on September 23, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 22 similar instances where the indicator moved out of overbought territory. In 22 of the 22 cases, the stock moved lower in the following days. This puts the odds of a move lower at 90%.
The Momentum Indicator moved below the 0 level on October 22, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on PULM as a result. In 91 of 103 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.
PULM moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for PULM crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 71%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PULM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.
PULM broke above its upper Bollinger Band on September 21, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PULM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 25 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. PULM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 88 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.260) is normal, around the industry mean (2.973). P/E Ratio (-1.291) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. PULM's P/S Ratio (2500.000) is slightly higher than the industry average of (438.009).
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PULM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
GERN | PULM | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 5 | 16 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 91 Overvalued | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 97 | 99 | |
PRICE GROWTH RATING 1..100 | 75 | 63 | |
P/E GROWTH RATING 1..100 | 19 | 25 | |
SEASONALITY SCORE 1..100 | n/a | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PULM's Valuation (88) in the Biotechnology industry is in the same range as GERN (91). This means that PULM’s stock grew similarly to GERN’s over the last 12 months.
PULM's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GERN (100). This means that PULM’s stock grew similarly to GERN’s over the last 12 months.
GERN's SMR Rating (97) in the Biotechnology industry is in the same range as PULM (99). This means that GERN’s stock grew similarly to PULM’s over the last 12 months.
PULM's Price Growth Rating (63) in the Biotechnology industry is in the same range as GERN (75). This means that PULM’s stock grew similarly to GERN’s over the last 12 months.
GERN's P/E Growth Rating (19) in the Biotechnology industry is in the same range as PULM (25). This means that GERN’s stock grew similarly to PULM’s over the last 12 months.
| GERN | PULM | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 76% | 1 day ago 90% |
| Stochastic ODDS (%) | 1 day ago 84% | 1 day ago 78% |
| Momentum ODDS (%) | 1 day ago 87% | 1 day ago 88% |
| MACD ODDS (%) | 1 day ago 79% | 1 day ago 67% |
| TrendWeek ODDS (%) | 1 day ago 84% | 1 day ago 71% |
| TrendMonth ODDS (%) | 1 day ago 84% | 1 day ago 86% |
| Advances ODDS (%) | 3 days ago 77% | 2 days ago 72% |
| Declines ODDS (%) | 1 day ago 79% | 10 days ago 86% |
| BollingerBands ODDS (%) | 1 day ago 85% | 2 days ago 90% |
| Aroon ODDS (%) | 1 day ago 82% | 1 day ago 90% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GERN’s FA Score shows that 1 FA rating(s) are green while PULM’s FA Score has 1 green FA rating(s).
- GERN’s FA Score: 1 green, 4 red.
- PULM’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GERN’s TA Score shows that 5 TA indicator(s) are bullish while PULM’s TA Score has 5 bullish TA indicator(s).
- GERN’s TA Score: 5 bullish, 4 bearish.
- PULM’s TA Score: 5 bullish, 5 bearish.
Price Growth
GERN (@Biotechnology) experienced а -2.52% price change this week, while PULM (@Biotechnology) price change was +13.77% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.
Reported Earning Dates
GERN is expected to report earnings on Nov 04, 2026.
PULM is expected to report earnings on Oct 22, 2026.
Industries' Descriptions
@Biotechnology (-1.10% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
GERN and
Correlation & Price change
A.I.dvisor indicates that over the last year, GERN has been loosely correlated with SER. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if GERN jumps, then SER could also see price increases.
| Ticker / NAME | Correlation To GERN | 1D Price Change % | ||
|---|---|---|---|---|
| GERN | 100% | -2.59% | ||
| SER - GERN | 66% Loosely correlated | -0.56% | ||
| VCYT - GERN | 44% Loosely correlated | -0.39% | ||
| TVTX - GERN | 40% Loosely correlated | -0.29% | ||
| RYTM - GERN | 40% Loosely correlated | +2.57% | ||
| SLDB - GERN | 40% Loosely correlated | -3.43% | ||
More | ||||
PULM and
Correlation & Price change
A.I.dvisor indicates that over the last year, PULM has been loosely correlated with ORMP. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if PULM jumps, then ORMP could also see price increases.
| Ticker / NAME | Correlation To PULM | 1D Price Change % | ||
|---|---|---|---|---|
| PULM | 100% | -9.55% | ||
| ORMP - PULM | 33% Loosely correlated | -0.48% | ||
| AARD - PULM | 31% Poorly correlated | -10.43% | ||
| INM - PULM | 30% Poorly correlated | -3.62% | ||
| ALT - PULM | 30% Poorly correlated | -2.69% | ||
| GERN - PULM | 27% Poorly correlated | -2.59% | ||
More | ||||